Antibacterial Agents TRIZ Cases

Peptides XH-12A through C overcome antibiotic resistance via parameter changes while maintaining low hemolytic activity.

Genetic fusion of a variable region to an Fc domain creates a single-chain polypeptide that yields high production efficiency while preventing co-stimulation.

Fragment-based virtual screening identifies indole derivatives that inhibit bacterial DNA replication while sparing human homologues.

Polysaccharide-protein conjugates with high sialic acid levels resolve limited vaccine coverage by inducing immunity against emerging GBS serotypes.

Astaxanthin and beta-carotene compositions inhibit H. pylori growth without inducing antibiotic resistance.

Controlled crystallization and drying yield homogeneous rifaximin polymorphs with defined water content.

Nicotinamide mononucleotide derivatives overcome antibiotic resistance by depleting bacterial NAD+ pools and mobilizing calcium reserves.

Cherry king hemp cultivar achieves high CBD yield while maintaining genetic uniformity and legal THC limits via controlled pollination.

CNCM I-3690 Lactobacillus rhamnosus resolves viability contradictions by inhibiting pathogens while surviving gastric stress.

Oral microbiota-derived molecule compositions utilize colonic delivery systems to target the gut.

Recombinant vaccine vector expressing Rhomboid polypeptide resolves vaccine-reaction morbidity while blocking Eimeria infection.

Reductive amination of oleofuran compounds produces tunable quaternary ammonium salts that overcome bacterial resistance.

Bacillus licheniformis and amyloliquefaciens strains reduce pathogen populations without the toxicity or nutrient degradation associated with chemical agents.

Isolating Bifidobacterium globosum from canine feces overcomes survival limits in acidic conditions, treating diarrhea by maintaining intestinal health.

Isolating adult liver progenitor cells via specific marker expression to expand transplantable cell supplies.

Lipidated di-peptides resolve low antimicrobial activity by combining fatty acids with peptide sequences to enhance reliability against pathogens.

Antibodies bind methanogen surface proteins to inhibit methane emissions in ruminants.

Direct plasma cell culture isolates rare antibodies efficiently, bypassing cumbersome gene cloning steps.

Substituted pyrrolo[2,3-d]pyrimidines inhibit E1 activating enzymes to overcome limited specificity of proteasome inhibitors.

Liposomal glutathione raises intracellular levels to enhance immune defense, reducing Klebsiella cultures and preventing antibiotic resistance.

Segmented amoxicillin formulations achieve specific partial AUC ratios to extend effective plasma levels while avoiding excessive absorption rates.

Acidification and sodium modification of montmorillonite yield high-purity material with optimized microstructure.

Optimizing the ratio of succinic to aconitic acid enhances biofilm disruption while reducing bacterial attachment without compromising safety.

Amylase inhibitor shields kiwifruit enzymes from salivary degradation, maintaining activity for gut health management.

Engineered CMV vectors use microRNA recognition elements to restrict viral replication in myeloid cells, preventing dissemination and enhancing vaccine safety.

Engineered gp130 muteins with specific amino acid substitutions increase binding affinity to the IL-6/sIL-6R complex, reducing required therapeutic dosage.

Specific bacteriophage compositions overcome antibiotic resistance by exploiting altered bacterial surface structures for selective lysis.

Replacing chlorhexidine salts with free base and fatty acids resolves skin irritation and adhesion loss under wet conditions.

Ultrasonic cavitation accelerates nucleophilic substitution to synthesize triazole acetic acid, resolving low yield and harsh conditions.

Conjugating daptomycin with siderophores exploits iron sequestration pathways to bypass outer membrane barriers in Gram-negative bacteria.

A CD16Int LDIB neutrophil subset biomarker identifies disease progression in severe COVID-19 patients.

ADI-PEG20 depletes arginine to kill ASS1-deficient breast cancer cells, addressing treatment-refractory tumors lacking metabolic targeting.

Synthesized adamantane and pinene derivatives inhibit Chlamydiales replication to reduce bacterial loads without fostering antibiotic resistance.

Modified pyridinium bromides overcome drug resistance and side effects in tuberculosis treatment.

Modified aminoglycoside compounds overcome resistance in gram-positive and gram-negative bacteria by introducing specific structural substituents.

Liposomes encapsulate modified mRNA to protect it from nuclease degradation and enhance intracellular expression efficiency.

Merging borate and phosphate buffers maintains physiological pH while inhibiting microbial growth in contact lens packaging.

Combining Lactobacillus plantarum CECT 7481 and Lactobacillus brevis CECT 7480 reduces dental plaque and acid production without harming commensal bacteria.

A unified chemical entity combines cannabinoid-CB1 antagonism with cholinesterase inhibition to address multiple therapeutic targets simultaneously.

Combining fulvic acid with meropenem creates an oral treatment for multi-drug resistant bacteria.

Combining this cyclic peptide with tigecycline reduces bacterial loads at lower doses, improving the risk-benefit ratio for resistant infections.

Removing CD3 zeta from CARs on gamma delta T cells restricts killing to phosphoantigen-presenting targets, reducing off-tumor toxicity.

Schinus terebinthifolia extracts inhibit bacterial quorum sensing, reducing Staphylococcus aureus virulence and antibiotic resistance.

Distinct rifaximin crystal structures modulate systemic absorption to enhance efficacy while minimizing resistance induction and adverse events.

Precise pH and ionic strength adjustments resolve structural stability contradictions, enabling reversible gelation for food texturing.

Carbapenem analogues target Pseudomonas aeruginosa via species-specific structural modifications, reducing adverse side effects and resistance development.

Mammalian host cells secrete recombinant FimH polypeptides, resolving low yield and purification complexity inherent in E. coli periplasmic extraction.

Chitosan carrier delivers chimeric fusion protein to fish digestive tract, resolving inadequate immune stimulation from traditional vaccination methods.